Protagonist Therapeutics Inc.
PTGX | NASDAQ
$144.98
+$1.98 (+1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$144.80
-$0.18 (-0.12%)
Pre-market:
Sep 22, 2026, 8:20 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 213.48M | 56.37M | 7.44M | 4.71M | 5.55M | 28.32M | 170.64M | 4.68M | 4.17M | 254.95M | 60M | n/a | n/a | n/a | n/a | n/a | 859K | 25.72M | 8.62M | 10.29M | 2.27M | 6.19M |
Cost of Revenue | n/a | 407K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 843K | 833K | 819K | n/a | n/a | n/a |
Gross Profit | 213.48M | 55.96M | 7.44M | 4.71M | 5.55M | 28.32M | 170.64M | 4.68M | 4.17M | 254.95M | 60M | n/a | n/a | n/a | n/a | n/a | 16K | 24.89M | 7.8M | 10.29M | 2.27M | 6.19M |
Operating Income | 158.77M | -3.65M | -50.36M | -46.42M | -42.04M | -19.31M | 126.78M | -41.45M | -38.79M | 206.31M | 23.05M | -38.33M | -42.35M | -36.02M | -36.52M | -32.3M | -41.44M | -21.11M | -37.92M | -33.93M | -30.88M | -24.02M |
Interest Income | 6.43M | 5.88M | 6.76M | 7.05M | 7.41M | 7.57M | 6.85M | 7.68M | 7.4M | 4.38M | 4.24M | 4.25M | 3.91M | 2.49M | 2.25M | 1.16M | 484K | 168K | 122K | 122K | 97K | 102K |
Pretax Income | 165.11M | 2.28M | -43.72M | -39.34M | -34.6M | -11.66M | 133.66M | -33.63M | -31.29M | 210.67M | 27.34M | -34.11M | -38.46M | -33.73M | -34.19M | -31.23M | -41.04M | -20.93M | -37.81M | -33.8M | -30.84M | -24M |
Net Income | 162.85M | 3.78M | -44.38M | -39.34M | -34.77M | -11.66M | 131.67M | -33.21M | -30.62M | 207.34M | 27.34M | -34.11M | -38.46M | -33.73M | -34.19M | -31.23M | -41.04M | -20.93M | -36.91M | -33.8M | -30.84M | -24M |
Selling & General & Admin | 12.65M | 13.28M | 11.43M | 11.13M | 10.55M | 11.74M | 8.95M | 10.16M | 9.44M | 14.91M | 8.05M | 7.66M | 9.17M | 8.61M | 6.63M | 6.9M | 6.85M | 9.68M | 6.44M | 7.26M | 6.72M | 5.97M |
Research & Development | 42.06M | 46.74M | 46.36M | 40M | 37.04M | 35.89M | 34.9M | 35.97M | 33.52M | 33.73M | 28.9M | 30.66M | 33.18M | 27.42M | 29.88M | 25.4M | 34.61M | 36.32M | 39.27M | 36.96M | 27.42M | 25.07M |
Other Expenses | n/a | -407K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -985K | -828K |
Operating Expenses | 54.71M | 59.61M | 57.79M | 51.13M | 47.59M | 47.63M | 43.86M | 46.13M | 42.96M | 48.64M | 36.95M | 38.33M | 42.35M | 36.02M | 36.52M | 32.3M | 41.46M | 46M | 45.71M | 44.21M | 33.15M | 30.21M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 54.71M | 60.02M | 57.79M | 51.13M | 47.59M | 47.63M | 43.86M | 46.13M | 42.96M | 48.64M | 36.95M | 38.33M | 42.35M | 36.02M | 36.52M | 32.3M | 42.3M | 46.83M | 46.53M | 44.21M | 33.15M | 30.21M |
Income Tax Expense | 2.27M | -1.5M | 666K | n/a | 172K | n/a | 1.99M | -420K | -676K | 3.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -900K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 65.94M | 65.09M | 63.57M | 63.77M | 63.51M | 62.96M | 62.33M | 61.77M | 61.31M | 60.86M | 60.39M | 59.18M | 56.78M | 50.57M | 49.26M | 48.8M | 48.85M | 48.67M | 48.15M | 47.99M | 44.86M | 44.22M |
Shares Outstanding (Diluted) | 71.01M | 70.49M | 63.57M | 63.77M | 63.51M | 62.96M | 66.41M | 61.77M | 61.31M | 63.6M | 61.8M | 59.18M | 56.78M | 50.57M | 49.26M | 49.11M | 49.05M | 48.75M | 48.15M | 47.99M | 44.86M | 44.22M |
EPS (Basic) | 2.47 | 0.06 | -0.69 | -0.62 | -0.55 | -0.19 | 2.11 | -0.54 | -0.50 | 3.41 | 0.45 | -0.58 | -0.68 | -0.62 | -0.64 | -0.62 | -0.83 | -0.43 | -0.77 | -0.70 | -0.69 | -0.54 |
EPS (Diluted) | 2.29 | 0.05 | -0.69 | -0.62 | -0.55 | -0.19 | 1.98 | -0.54 | -0.50 | 3.26 | 0.44 | -0.58 | -0.68 | -0.62 | -0.64 | -0.61 | -0.83 | -0.43 | -0.77 | -0.70 | -0.69 | -0.54 |
EBITDA | 165.11M | 2.69M | -43.34M | -38.98M | -34.3M | -11.42M | 134.2M | -32.98M | -29.82M | 210.9M | 28.17M | -33.28M | -37.64M | -32.89M | -31.7M | -30.38M | -40.19M | -20.1M | -36.99M | -33.1M | -30.66M | -23.84M |
EBIT | 165.11M | 2.28M | -43.72M | -39.34M | -34.6M | -11.66M | 133.66M | -33.63M | -31.29M | 210.67M | 27.34M | -34.11M | -38.46M | -33.73M | -32.54M | -31.23M | -41.04M | -20.93M | -37.81M | -33.8M | -30.84M | -24.02M |
Depreciation & Amortization | n/a | 407K | 376K | 361K | 304K | 239K | 536K | 647K | 1.48M | 236K | 832K | 827K | 821K | 832K | 840K | 853K | 843K | 833K | 819K | 704K | 185K | 180K |
Add to Watchlist
Select watchlists to add or remove PTGX